Skip to content

Validation of a Novel Thoracic Neoplasm Radiotherapy Image Guidance Technique: A Pilot Study

Validation of a Novel Thoracic Neoplasm Radiotherapy Image Guidance Technique: A Pilot Study

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00585819
Enrollment
0
Registered
2008-01-03
Start date
2007-05-31
Completion date
2012-12-31
Last updated
2012-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

The overall, broad objective of this study is to pilot the BSD technique. The specific purpose of this particular study is to generate pilot data to validate several crucial steps of the BSD technique, in particular steps 1, 2, and 4. Radiation treatments will proceed per standard of care, and will not be modified in any way during this protocol. This study is a non-treatment protocol.

Interventions

PROCEDUREreproduce breathing cycle utilizing spirometry

reproduce breathing cycle utilizing spirometry

PROCEDUREFreebreathing in Body fix mold

Freebreathing in Body fix mold

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any thoracic neoplasm scheduled to undergo radiation therapy * 18 years or older * Must be treated with radiation as part of standard of care * Able to tolerate the mouthpiece for spirometry and video glasses * Ability to provide written informed consent

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Reproducibility of the guided breathing cycle6 weeks

Secondary

MeasureTime frame
Stability of motion envelope derived from initial 4D imaging compared to CT's obtained throughout the course of therapy6 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026